Abstract
Introduction

Macroautophagy (herein autophagy) refers to an intracellular catabolic pathway that involves the delivery of cytoplasmic cargo to the lysosome. Autophagy is characterized by the appearance of double membrane cytoplasmic vesicles (autophagosomes) that fuse and are then destroyed by the lysosomal system [1, 2]. Autophagy occurs at low basal levels in virtually all cells to perform homeostatic functions such as protein and organelle turnover [1, 2]. It is rapidly increased when cells need to generate intracellular nutrients and energy such as those encountered during starvation, growth factor withdrawal or high bioenergetic demands [1, 2]. Neonates deficient in autophagy-related gene (Atg)5 die within 12 hrs after birth compared to wild-type (wt) counterparts, suggesting autophagy is essential between the time of birth and suckling [3]. The molecular cascade that regulates and executes autophagy has been extensively studied in yeast and has resulted in the identification of a number of Atgs [1, 2]. One of the key pathways that promotes autophagy requires two ubiquitin-like systems, one leading to the conjugation of Atg12 to Atg5 and the second converting the microtubule-associated protein 1 light chain 3 (LC3 or Atg8) soluble form (LC3-I) to the autophagic vesicleassociated form (LC3-II) [1, 2].
The role of autophagy in maintaining macromolecular synthesis and ATP production is likely to be a critical mechanism underlying its evolutionarily conserved prosurvival function. There is evidence that autophagy may be an alternative and adaptive response to maintain cell survival under different stress conditions [1] [2] [3] . For [11] . The transduction pathway is generally initiated at cytokine cell surface receptors, and results in STAT phosphorylation, dimerization and translocation to the nucleus [11] . STATs have important roles in homeostasis, development and cell fate decisions [11] . Previously, we reported that STAT1 plays an important role in enhancing apoptotic cell death in cardiac myocytes following I/R injury [12, 13] .
Here 
Simulated ischemia in isolated cardiomyocytes
Isolated cardiomyocytes were isolated as previously described [7, 12] and exposed to simulated ischemia in a modified Esumi buffer [7, 12] 
Western blotting
Western blotting was performed as described [12] 
Electron microscopy
Tissue samples were fixed and embedded for electron microscopy analysis, as previously described, with minimal modifications [6] .
Statistical analysis
Results are expressed as mean S.E.M. (analyzed by the GraphPad Software). Differences were considered statistically significant at values of P Ͻ 0.05.
Results
STAT1 deficiency reduces infarct size hearts and show increased autophagy after I/R in the intact heart following I/R
We have shown previously that activated STAT1 can promote apoptotic cell death in isolated cardiac myocytes and in the isolated perfused heart exposed to I/R injury [12] . Ϫ/Ϫ hearts exposed both to I alone and to I/R (Fig. 3A) . This lack of change in the mRNA levels was also validated by qPCR (Fig. 3B) . Similar results were also observed with Atg12 and Atg5 mRNA levels (data not shown). These results Fig. 1 (A Figure 4A , [18] . The generation of ROS during I/R has been shown both to activate STAT1 [19] and to induce apoptosis, and ROS have been implicated in I/R-induced cardiac myocyte apoptosis [7] . Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) [20] . In addition, we showed that IFN-␥, a potent activator of STAT1, not only enhanced infarct size but also could overcome the protective effects of tempol [20] . The results suggest a potential mechanism of action for the cardioprotective effects of tempol by partly inhibiting the ROS-STAT1 activated pathway and thus potentially enhancing cardiac autophagy [20] .
Inhibition of STAT1 enhances autophagy and autophagic flux in cardiac myocytes
Previously we have shown that inhibiting STAT1 activity with the polyphenol epigallocatechin-3-gallate (ECGC) protects both primary cardiac myocytes and the intact heart from I/R injury [16]. We next tested whether EGCG not only inhibits STAT1 but also enhances autophagy in primary cardiac myocytes. As shown in
primary cardiac myocytes exposed to simulated I/R induced LC3-II levels after 90 min. Moreover, interferon (IFN)-␥-treated primary cardiac myocytes activated STAT1 and reduced LC3-II levels. In contrast, ECGC known to inhibit STAT1 phosphorylation [16], significantly enhanced the levels of LC3-II levels (Fig. 4B). Thus, these data demonstrate that autophagy can be modulating by regulating STAT1 activity in cardiac myocytes. To further evaluate the role of STAT1 in modulating autophagic activity/ flux, we used STAT1-deficient MEFs and took advantage of a recently described quantitative method which relies on the preferential
) and STAT1 Ϫ/Ϫ hearts were subjected to ex vivo I/R. LC3-I and LC3-II Western blotting of LC3-II. Levels appeared raised during ischaemia in the STAT1 Ϫ/Ϫ animals. (C) Western blot analysis of Beclin 1 levels is enhanced during ischaemia in STAT1 Ϫ/Ϫ compared to wts. Densitometry demonstrated significant increase of Beclin 1 protein levels in STAT1 Ϫ/Ϫ hearts (lower panel). (D) Western blots analysis of Atg12 levels in wt (STAT
IFN-␥ has also been reported to play an important role in promoting autophagy and removal of intracellular pathogens and therefore links the inflammatory and autophagic pathways in the innate immune system via inducing IFN-␥ inducible proteins [21, 22] . The inflammatory response is also enhanced following IR and this causes cardiac injury [23] [24] .
, because inhibiting the inflammatory response reduces myocardial injury following IR. Whether IFN-␥ via JAK-STAT1 activation is required for promoting autophagy in immune cells is unclear because IFN-␥ can also mediate effects independent of STAT1
Flavonoids exhibit a variety of beneficial effects in cardiovascular diseases and this has been attributed mainly to their antioxidant action. Recently, we also demonstrated additional cardioprotective mechanisms of some flavonoids through their inhibition of STAT1 activation [16, 25] . Furthermore, biochemical and computer modelling analysis indicated a direct interaction between STAT1 and flavonoids which correlated with their anti-STAT1 activity [26] Thus, those flavonoids (myricetin and delphinidin) that had higher affinity binding to STAT1 were associated with more pronounced protective effects against both cardiac injury and haemodynamic impairment. Resveratrol is another flavanoid that is attracting increased attention due to its diverse health benefits, especially in the case of cardiovascular disease, and has also been found to induce autophagy which may be mediated by its reported inhibition of STAT1 activity [27] . Together, these data provide further evidence that STAT1 could be a relevant target for protection against I/R injury in the heart and further suggest that agents that inhibit STAT1 are also agents that may promote autophagy.
The p53 transcription factor is a key regulator of the cellular response to acute stress and also a tumour suppressor [28] . Recent studies have shown that p53 can modulate autophagy in a dual fashion depending on the sub-cellular localization. Thus, nuclear and transcriptional actions of p53 are known to transactivate pro-apoptotic and autophagic genes [28, 29] . In contrast, cytoplasmic p53 also acts at the mitochondrial level to induce apoptosis but it inhibits autophagy [30] . Moreover, inhibiting p53 by RNA interference also induces autophagy [30] . In the present study the molecular mechanism on how STAT1 inhibits autophagy is still unclear. Our original findings that STAT1 is able to interact 
